EcoR1 Capital, LLC 13D and 13G filings for Solid Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-09 5:55 pm Sale | 2022-12-31 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital, LLC | 0 0.000% | -613,513![]() (Position Closed) | Filing |
2022-02-14 3:19 pm Purchase | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital, LLC | 613,513 8.300% | 81,667![]() (+15.36%) | Filing |
2021-02-16 12:11 pm Purchase | 2020-12-31 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital, LLC | 531,847 9.400% | 180,180![]() (+51.24%) | Filing |
2020-11-02 4:04 pm Purchase | 2020-10-23 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital, LLC | 351,667 9.800% | 351,667![]() (New Position) | Filing |